BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14614017)

  • 1. Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.
    Jørgensen K; Holm R; Maelandsmo GM; Flørenes VA
    Clin Cancer Res; 2003 Nov; 9(14):5325-31. PubMed ID: 14614017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
    Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
    Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
    Flørenes VA; Maelandsmo GM; Holm R; Reich R; Lazarovici P; Davidson B
    Am J Clin Pathol; 2004 Sep; 122(3):412-20. PubMed ID: 15362372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
    Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
    Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
    J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
    Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
    Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K; Davidson B; Flørenes VA
    Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of nuclear extracellular signal-regulated kinase 1 and 2 signaling during cell cycle reentry distinguishes proliferation from apoptosis in response to asbestos.
    Yuan Z; Taatjes DJ; Mossman BT; Heintz NH
    Cancer Res; 2004 Sep; 64(18):6530-6. PubMed ID: 15374964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.
    Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ
    Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
    Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
    Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development.
    Alonso M; Melani M; Converso D; Jaitovich A; Paz C; Carreras MC; Medina JH; Poderoso JJ
    J Neurochem; 2004 Apr; 89(1):248-56. PubMed ID: 15030409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
    Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
    Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.
    Johansen C; Kragballe K; Westergaard M; Henningsen J; Kristiansen K; Iversen L
    Br J Dermatol; 2005 Jan; 152(1):37-42. PubMed ID: 15656798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.